Recombinant Human IL-29 Protein

<strong>Recombinant Human IL-29 Protein</strong>_x000D_ <strong>Catalog number:</strong> B2015926_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 25 and 30 kDa, monomer, glycosylated_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> Cytokine Zcyto21, IFN lambda 1, IFNL1, IFN-lambda 1, IL 29, IL29, IL-29, Interferon lambda 1, Interleukin 29_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors Immunol Rev. 2004 Dec;202:8-32._x000D_ 2: Munir A, Ahmed N, Akram M, Fujimura NA, Tahir S, Malik K. Enhanced soluble expression of active recombinant human interleukin-29 using champion pET SUMO system Biotechnol Lett. 2023 Aug;45(8):1001-1011._x000D_ 3: Akram M, Khan MA, Ahmed N, Bhatti R, Pervaiz R, Malik K, Tahir S, Abbas R, Ashraf F, Ali Q. Cloning and expression of an anti-cancerous cytokine: human IL-29 gene in Chlamydomonas reinhardtii AMB Express. 2023 Feb 25;13(1):23._x000D_ 4: Lu Y, Li L, Chen W, Wu M. Enhanced Anti-Tumor (Anti-Proliferation) Activity of Recombinant Human Interleukin-29 (IL-29) Mutants Using Site-Directed Mutagenesis Method Appl Biochem Biotechnol. 2015 Nov;177(5):1164-75._x000D_ 5: Hasegawa K, Tagawa M, Takagi K, Tsukamoto H, Tomioka Y, Suzuki T, Nishioka Y, Ohrui T, Numasaki M. Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1 Cancer Gene Ther. 2016 Aug;23(8):266-77._x000D_ 6: Chen W, Zhu R, Ge C, Lu Y, Li L, Li F, Wu M. [Site-directed mutagenesis of human IL-29 and antineoplastic activity of the recombinant human IL-29 variant] Sheng Wu Gong Cheng Xue Bao. 2015 May;31(5):702-10._x000D_ 7: Li M, He S. Purification and characterization of recombinant human interleukin-29 expressed in Escherichia coli J Biotechnol. 2006 Apr 10;122(3):334-40._x000D_ 8: Meager A, Heath A, Dilger P, Zoon K, Wadhwa M; Participants of the Collaborative Study. Standardization of human IL-29 (IFN-λ1): establishment of a World Health Organization international reference reagent for IL-29 (IFN-λ1) J Interferon Cytokine Res. 2014 Nov;34(11):876-84._x000D_ 9: Megjugorac NJ, Gallagher GE, Gallagher G. IL-4 enhances IFN-lambda1 (IL-29) production by plasmacytoid DCs via monocyte secretion of IL-1Ra Blood. 2010 May 27;115(21):4185-90._x000D_ <a>10: Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM. IL-28, IL-29 and their class II cytokine receptor IL-28R Nat Immunol. 2003 Jan;4(1):63-8. </a>_x000D_ _x000D_ <strong>Products Related to Recombinant Human IL-29 Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>